We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » REVISED GUIDANCE CALLS FOR CLINICAL DATA IN OC LABELING
REVISED GUIDANCE CALLS FOR CLINICAL DATA IN OC LABELING
March 4, 2004
Makers of combined oral contraceptives (OCs) should simplify patient labeling sections and incorporate more clinical trial data in their labeling, according to a recently revised FDA guidance for the products.